Selank: What the Research Shows
Also known as: TP-7
A synthetic peptide analog of tuftsin, approved in Russia for anxiety and studied for nootropic and immunomodulatory properties.
This content is for educational purposes only and is not medical advice. Consult a qualified healthcare provider before making any health decisions. Full disclaimer
Quick Facts
Regulatory Status
Not FDA-approved. Approved in Russia as an anxiolytic. Available only as a research compound in the US.
Researched Applications
Key Research (1 studies cited)
Anxiolytic-like action of selank in the open field test
animalSeredenin SB, et al. (2002) — Bulletin of Experimental Biology and Medicine
Animal study demonstrating selank produced anxiolytic effects comparable to benzodiazepines without sedation or dependence.
Key finding: Selank demonstrated anxiolytic activity comparable to standard anxiolytics without sedative effects or addictive potential.
PubMed: 12459849About this article: Written by the PeptideMark Research Team. Last reviewed 2026-03-11. All factual claims are cited to peer-reviewed sources. PubMed links open in a new tab for independent verification. Editorial methodology · Medical disclaimer
The Peptide Brief
Weekly peptide research digest. No spam.